Liao Chia-Jung, Hsieh Chia-Hsun, Hung Feng-Chun, Wang Hung-Ming, Chou Wen-Pin, Wu Min-Hsien
Graduate Institute of Biomedical Engineering, Chang Gung University, Taoyuan City 33302, Taiwan.
Division of Haematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital (Linkou), Taoyuan City 33302, Taiwan.
Cancers (Basel). 2019 Jun 6;11(6):783. doi: 10.3390/cancers11060783.
Conventional positive and negative selection-based circulating tumor cell (CTC) isolation methods might generally ignore metastasis-relevant CTCs that underwent epithelial-to- mesenchymal transition and suffer from a low CTC purity problem, respectively. To address these issues, we previously proposed a 2-step CTC isolation method integrating a negative selection CTC isolation and subsequent spheroid cell culture. In addition to its ability to isolate CTCs, more importantly, the spheroid cell culture used could serve as a cell culture model mimicking the process of new tumor tissue formation during cancer metastasis. Therefore, it is promising not only to selectively isolate metastasis-relevant CTCs but also to test the potential of cancer metastasis and thus the prognosis of disease. To explore these issues, experiments were performed. The key findings of this study demonstrated that the method was able to harvest both epithelial (E)- and mesenchymal (M)-type CTCs without selection bias. Moreover, both the M-type CTC count and the information obtained from the multidrug resistance-associated protein 2 (MRP2) and MRP5 gene expression analysis of the CTCs isolated via the 2-step CTC isolation method might be able to serve as prognostic factors for progression-free survival in head and neck squamous cell carcinoma.
传统的基于正负选择的循环肿瘤细胞(CTC)分离方法,可能通常会分别忽略经历上皮-间质转化的与转移相关的CTC,以及存在CTC纯度低的问题。为了解决这些问题,我们之前提出了一种两步法CTC分离方法,该方法整合了负选CTC分离及随后的球状体细胞培养。除了其分离CTC的能力外,更重要的是,所采用的球状体细胞培养可作为一种细胞培养模型,模拟癌症转移过程中新肿瘤组织形成的过程。因此,不仅有望选择性地分离与转移相关的CTC,而且有望测试癌症转移的潜力以及疾病的预后。为了探究这些问题,我们进行了实验。本研究的关键发现表明,该方法能够无选择偏向地收获上皮(E)型和间质(M)型CTC。此外,通过两步法CTC分离方法分离的CTC的M型CTC计数以及从多药耐药相关蛋白2(MRP2)和MRP5基因表达分析中获得的信息,可能都能够作为头颈部鳞状细胞癌无进展生存期的预后因素。